Tharun is a Chartered Financial Analyst from the CFA Institute, U.S. A graduate from Loyola College, Chennai, he started his career in Goldman Sachs at their Bangalore office. Prior to his current role at Proactive Investors, he worked as an equity analyst at a global research and analytics company in Mumbai, assisting institutional clients across Asia.
Last month, Edison increased their valuation for Regeneus to 87 cents per share.
The medical cannabis company is vertically integrated from 'farm to pharma'.
There were no adverse safety findings and excellent drug-like properties were confirmed.
A strategic review will see more focus on the largest global markets for medicinal cannabis.
Technegas is inhaled by patients and allows the diagnosis of multiple respiratory diseases via imaging and analytical software
The latest investment takes Star Bright’s total interest in the company to 19.99% of issued shares.
Non-executive director Dennis Eck purchased $1 million worth of stock for 38 cents.
The offer was at the same price as the recent share placement to sophisticated and institutional investors for $9 million.